Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status

Morris D. Groves, Vinay K. Puduvalli, Charles A. Conrad, Mark R. Gilbert, W. K.Alfred Yung, Kurt Jaeckle, Vivien Liu, Kenneth R. Hess, Kenneth D. Aldape, Victor A. Levin

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status'. Together they form a unique fingerprint.

Medicine & Life Sciences